Group One Trading, L.P. Magenta Therapeutics, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$6.1 - $7.94 $4,880 - $6,352	-800 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$6.52 - $8.94 $1,955 - $2,682	300 Added 60.0%	800 $5,000
Q2 2020 Aug 13, 2020	BUY	$6.18 - $10.76 $1,854 - $3,228	300 Added 150.0%	500 $4,000
Q1 2020 May 13, 2020	SELL	$6.03 - $15.24 $1,206 - $3,048	-200 Reduced 50.0%	200 $1,000
Q4 2019 Feb 10, 2020	BUY	$9.07 - $15.84 $3,628 - $6,336	400 New	400 $6,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.